2011•Proceedings of the National Academy of SciencesOpen access
Long-term RNA interference gene therapy in a dominant retinitis pigmentosa mouse model
Li Jiang, Houbin Zhang, Alexander M. Dizhoor, Sanford L. Boye, William W. Hauswirth, Jeanne M. Frederick, Wolfgang Baehr
Open full text 47 citations
Abstract
RNA interference (RNAi) gene silencing is a potential therapeutic strategy for dominant retinal degeneration disorders. We used self-complementary (sc) AAV2/8 vector to develop an RNAi-based gene therapy in a dominant retinal degeneration mouse model expressing bovine GCAP1(Y99C). We established an in vitro shRNA screening assay based on EGFP-tagged bovine GCAP1, and identified a shRNA that effectively silenced the bovine GCAP1 transgene with ∼80% efficiency. Subretinal injection of scAAV2/8 carrying shRNA expression cassette showed robust expression as early as 1 wk after injection. The gene silencing significantly improved photoreceptor survival, delayed disease onset, and increased visual function. Our results provide a promising strategy toward effective RNAi-based gene therapy by scAAV2/8 delivery for dominant retinal diseases.